The “Psychosomatic Consultation in the Workplace” – a new model of care at the interface of company-supported mental health care and consultation-liaison psychosomatics

The “Psychosomatic Consultation in the Workplace” – a new model of care at the interface of company-supported mental health care and consultation-liaison psychosomatics - PSIB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003184

Enrollment

280

Registered

2012-01-13

Start date

2011-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression (ICD-10 F30 ff), Anxiety (ICD-10 F40 ff), Somatisation (ICD-10 F45 ff), Burnout Syndrom (ICD-10 Z73) F32 F33 F45 Z73 F34 F40 F41 F43

Interventions

Group 1: Three large companies (2 of them metal-working, 1 security systems) in cooperation with the local psychosomatic clinics have established the “psychosomatic consultation at the workplace“ in t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients utilising the offer within the course of recruitment

Exclusion criteria

Exclusion criteria: Age < 18 years, no employment (exclusion before data analysis)

Design outcomes

Primary

Measure	Time frame
Work ability (WAI) (research questoin 2) Identifying different types of patients with specific trait combinations while controlling for the setting (outpatient clinic vs. workplace). (research question 1, cross-sectional part of the study)	—

Secondary

Measure	Time frame
Quality of life (SF-12), clinical symptoms: depression (PHQ-9), somatoform symptom severity (PHQ-15), anxiety (PHQ-7), work related stress (irritationscale, maslach burnout inventory). Identifying changes in disease severity, quality of life and ability to work 12 weeks after fist contact, Measure for the extent to which recommendations have been implemented, Patient satisfaction, Exploration of the feedback received from the company staff (qualitative).	—

Measure

Time frame

Quality of life (SF-12), clinical symptoms: depression (PHQ-9), somatoform symptom severity (PHQ-15), anxiety (PHQ-7), work related stress (irritationscale, maslach burnout inventory). Identifying changes in disease severity, quality of life and ability to work 12 weeks after fist contact, Measure for the extent to which recommendations have been implemented, Patient satisfaction, Exploration of the feedback received from the company staff (qualitative).

—

Countries

Germany

Contacts

Public ContactEva Rothermund

Universitätsklinik für Psychosomatische Medizin und Psychotherapie Ulm

eva.rothermund@uniklinik-ulm.de0049 731 500 61848

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 25, 2026